The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from the phase IIIb complement-1 study of ribociclib (RIB) plus letrozole (LET) in the treatment of HR+, HER2-advanced breast cancer (ABC).
 
Michelino De Laurentiis
Honoraria - Amgen; Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genomic Health; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - Novartis; Roche
Research Funding - Eisai; Italfarmaco; Roche
Travel, Accommodations, Expenses - Amgen; Celgene; Eisai; Genomic Health; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche
 
Simona Borstnar
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; Novartis; Pfizer; Roche
 
Mario Campone
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Abbvie (Inst); Accord Healthcare (Inst); AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Sandoz-Novartis (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
Other Relationship - Roche
 
Ellen Warner
Travel, Accommodations, Expenses - Novartis
 
Javier Salvador Bofill
Consulting or Advisory Role - Lilly; Lilly; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche
Other Relationship - Novartis; Novartis; Pfizer; Pfizer; Roche; Roche
 
William Jacot
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Susan Faye Dent
Honoraria - amgen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; novartis; Pfizer; Roche Canada
Research Funding - Novartis (Inst)
 
Miguel Martin
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Novartis (Inst); Roche (Inst)
 
Alistair E. Ring
Consulting or Advisory Role - Lilly; Merck; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Puma Biotechnology (Inst)
 
Paul H. Cottu
Honoraria - Lilly; NanoString Technologies (Inst); Novartis (Inst); Pfizer; Roche
Consulting or Advisory Role - Lilly; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - pfizer; Roche
 
Janice M. Lu
Honoraria - Daiichi Sankyo; Novartis; Pfizer; Puma Biotechnology
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Novartis; Pfizer; Puma Biotechnology
Travel, Accommodations, Expenses - Daiichi Sankyo; Novartis; Pfizer
 
Eva Ciruelos
Consulting or Advisory Role - Lilly; Lilly; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche
Other Relationship - Roche
 
Hamdy A. Azim
Employment - Innate Pharma (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; miRagen; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Hikma Pharmaceuticals; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; miRagen; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Bayer; Janssen; MSD; Novartis; Pfizer; Roche
 
Sanjoy Chatterjee
No Relationships to Disclose
 
Katie Zhou
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jiwen Wu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Nii Ankrah
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Claudio Zamagni
Honoraria - Istituto Gentili; Pierre Fabre; Takeda; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Eisai; IQVIA; Lilly; Novartis; Pfizer; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Celgene (Inst); Medivation (Inst); Morphotek (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Seagen (Inst); Synthon (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Celgene; Istituto Gentili; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche; Tesaro